The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-22
DOI
10.3389/fimmu.2018.02585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current and emerging therapeutic targets for IBD
- (2017) Markus Neurath Nature Reviews Gastroenterology & Hepatology
- Loss of Response to Anti-TNFs: Definition, Epidemiology and Management
- (2016) Giulia Roda et al. Clinical and Translational Gastroenterology
- Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis
- (2015) Rana Herro et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis
- (2015) Rana Herro et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
- (2014) Aleksandar D. Kostic et al. GASTROENTEROLOGY
- The Tumor Necrosis Factor Family Member TNFSF14 (LIGHT) Is Required for Resolution of Intestinal Inflammation in Mice
- (2014) Petra Krause et al. GASTROENTEROLOGY
- Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
- (2014) Shravan Madireddi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells
- (2014) E Macho-Fernandez et al. Mucosal Immunology
- HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria
- (2012) Jr-Wen Shui et al. NATURE
- Lymphotoxin Beta Receptor Signaling in Intestinal Epithelial Cells Orchestrates Innate Immune Responses against Mucosal Bacterial Infection
- (2010) Yugang Wang et al. IMMUNITY
- The unexpected role of lymphotoxin β receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development
- (2010) M J Wolf et al. ONCOGENE
- Inflammatory Bowel Disease
- (2009) Clara Abraham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners
- (2009) Marcos W. Steinberg et al. Seminars in Immunopathology
- TL1A (TNFSF15) Regulates the Development of Chronic Colitis by Modulating Both T-Helper 1 and T-Helper 17 Activation
- (2008) Hidetoshi Takedatsu et al. GASTROENTEROLOGY
- A crucial role for HVEM and BTLA in preventing intestinal inflammation
- (2008) Marcos W. Steinberg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation—Opposite functions for surface lymphotoxin expressed by T and B lymphocytes
- (2007) Michaela Jungbeck et al. MOLECULAR IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started